• letlifehappen's Avatar

    letlifehappen posted a blog post

    By: Jessica Hergert From: onclive.com Nearly 1 year following the first checkpoint inhibitor approval in advanced triple-negative breast cancer, additional immunotherapeutic agents are poised to enter the field, according to Rita Nanda, MD. “Historically, breast cancer was not believed to be an immunogenically active tumor [type],” said Nanda. “We have seen some emerging—likely practice-changing—data that may lead to approvals of ...
    The post Immunotherapy Continues to Show Promise in TNBC appeared first on Let Life Happen.